Suchergebnisse - (Person:"Wagner, Kathryn R")

PubPharm (7)

1

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy : a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13

2

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13

3

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13

4

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab

enthalten in: Journal of neurology | 2022

von Sherlock, S. | Palmer, J. | Wagner, K. | +13

5

Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy

enthalten in: Muscle & nerve | 2015

von Leung, D. | Carrino, J. | Wagner, K. | +1

6

Whole‐body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy

enthalten in: Muscle & nerve | 2015

von Leung, D. | Carrino, J. | Wagner, K. | +1

7

Magnetic resonance imaging phenotyping of Becker muscular dystrophy

enthalten in: Muscle & nerve | 2014

von Faridian-Aragh, N. | Wagner, K. | Leung, D. | +1

1
[1]